Latest filing published 29 Apr 2026 for Jiangsu Hengrui Pharmaceuticals Co., Ltd..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Lou Liguang: trading record in brief
This profile gathers the share dealings of Lou Liguang in Jiangsu Hengrui Pharmaceuticals Co., Ltd., where the filings describe the role as chief executive. In total, 2 filings cover trades dated 16 April 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Most recently, on 29 April 2026, the filings show a transaction in Jiangsu Hengrui Pharmaceuticals Co., Ltd. Source: insider filings from HKEX. Past trades are no guide to future returns.
Companies and markets linked to Lou Liguang
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,180 sharesShareXHKGHKEX:DA20260428E00443
- 1,000 sharesShareXHKGHKEX:DA20260428E00444
2 of 2 declarations